Dataset Information

Management of acquired hemophilia A: results from the Spanish registry.

ABSTRACT: The Spanish Acquired Hemophilia A (AHA) Registry is intended to update the status of AHA in Spain. One hundred and fifty-four patients were included and retrospectively followed for a median of 12 months. Patients were predominantly male (56.3%), with median age at diagnosis of 74 years. AHA was more frequently idiopathic (44.1%) and autoimmune disorder-associated (31.7%). Thirty-four percent of patients were on antithrombotic therapy at diagnosis. Hemostatic treatment was used in 70% of patients. Recombinant activated factor VII was more frequently infused (60.3% vs 20.6% activated prothrombin complex concentrate). Only 1 patient did not achieve control of hemorrhage. Complete remission (CR) was achieved by 84.2% of cases after immunosuppressive therapy. Steroids alone were less efficient than the other strategies (68.2% vs 87.2%, P = .049), whereas no differences existed among these (steroids/cyclophosphamide, 88.5%, vs steroids/calcineurin inhibitors, 81.2%, vs rituximab-based regimens, 87.5%). Female sex and high inhibitor levels influenced CR negatively. Thirty-six deaths (23.8%) were reported. Main causes of death were infection (15 patients, 9.9%) and hemorrhage (5 patients, 3.3%). All hemorrhage-related and half the infection-related deaths occurred within 2 months of diagnosis. Prior antithrombotic therapy was inversely associated with survival, irrespective of age. Median age of nonsurvivors was significantly higher (79 vs 73 years in survivors). Patients dying of infection were older than the other nonsurvivors (85 vs 78 years). In summary, fatal infection in the first months is common in our series. Antithrombotic therapy is associated with mortality. Particular care should be taken to avoid misdiagnosis.

SUBMITTER: Mingot-Castellano ME

PROVIDER: S-EPMC8679668 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Management of acquired hemophilia A: results from the Spanish registry.

Mingot-Castellano María-Eva ME Pardos-Gea Josep J Haya Saturnino S Bastida-Bermejo José-María JM Tàssies Dolors D Marco-Rico Ana A Núñez Ramiro R García-Candel Faustino F de Mora María-Carmen Fernández-Sanchez MF Soto Inmaculada I Álvarez-Román María-Teresa MT Asenjo Susana S Carrasco Marina M Lluch-García Rafael R Martín-Antorán José-Manuel JM Rodríguez-Alén Agustín A Roselló Elena E Torres-Miñana Laura L Marcellini-Antonio Shally S Moretó-Quinana Ana A Rodríguez-García José-Antonio JA Aguinaco-Culebras Reyes R Alonso-Escobar Nieves N Cervero-Santiago Carlos C Fernández-Mosteirín Núria N Martínez-Badás María-Paz MP Pérez-Sánchez Montserrat M Pérez-Montes Rocío R Rodríguez-González Ramón R Uribe-Barrientos Marisol M Caparrós-Miranda Isabel Socorro IS Iglesias-Fernández Miriam M Baena Ángela Á Rodríguez-López Manuel M Sebrango-Sandia Ana A Vázquez-Fernández Irene I Marco Pascual P

Blood advances 20211001 19

The Spanish Acquired Hemophilia A (AHA) Registry is intended to update the status of AHA in Spain. One hundred and fifty-four patients were included and retrospectively followed for a median of 12 months. Patients were predominantly male (56.3%), with median age at diagnosis of 74 years. AHA was more frequently idiopathic (44.1%) and autoimmune disorder-associated (31.7%). Thirty-four percent of patients were on antithrombotic therapy at diagnosis. Hemostatic treatment was used in 70% of patient ...[more]

PMID: 34521101

Similar Datasets

Project description:IntroductionPenile cancer (PC) is a rare malignancy with an overall incidence in Europe of 1/100,000 males/year. In Europe, few studies report the epidemiology, risk factors, clinical presentation, and treatment of PC. The aim of this study is to present an updated outlook on the aforementioned factors of PC in Spain.Materials and methodsA multicentric, retrospective, observational epidemiological study was designed, and patients with a new diagnosis of PC in 2015 were included. Patients were anonymously identified from the Register of Specialized Care Activity of the Ministry of Health of Spain. All Spanish hospitals recruiting patients in 2015 were invited to participate in the present study. We have followed a descriptive narration of the observed data. Continuous and categorical data were reported by median (p25th-p75th range) and absolute and relative frequencies, respectively. The incidence map shows differences between Spanish regions.ResultsThe incidence of PC in Spain in 2015 was 2.55/100,000 males per year. A total of 586 patients were identified, and 228 patients from 61 hospitals were included in the analysis. A total of 54/61 (88.5%) centers reported ≤ 5 new cases. The patients accessed the urologist for visually-assessed penile lesions (60.5%), mainly localized in the glans (63.6%). Local hygiene, smoking habits, sexual habits, HPV exposure, and history of penile lesions were reported in 48.2%, 59.6%, 25%, 13.2%, and 69.7%. HPV-positive lesions were 18.1% (28.6% HPV-16). The majority of PC was squamous carcinoma (95.2%). PC was ≥cT2 in 45.2% (103/228) cases. At final pathology, PC was ≥pT2 in 51% of patients and ≥pN1 in 17% of cases. The most common local treatment was partial penectomy (46.9% cases). A total of 47/55 (85.5%) inguinal lymphadenectomies were open. Patients with ≥pN1 disease were treated with chemotherapy in 12/39 (40.8%) of cases.ConclusionsPC incidence is relatively high in Spain compared to other European countries. The risk factors for PC are usually misreported. The diagnosis and management of PC are suboptimal, encouraging the identification of referral centers for PC management.

Dataset Information

Management of acquired hemophilia A: results from the Spanish registry.

Publications

Management of acquired hemophilia A: results from the Spanish registry.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets